Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
4 hedge funds and large institutions have $319K invested in Medigus Ltd. Series C Warrant in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
61% less capital invested
Capital invested by funds: $811K → $319K (-$492K)
Top Buyers
Top Sellers
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
MDGSW Hedge Fund Activity: Q4 2021 in Review
4 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q4 2021, worth a combined $319K — down 61% from $811K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MDGSW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Warberg Asset Management, exiting entirely with an estimated $9K sold.
- 4 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q4 2021, down from 5 in Q3 2021.
- Funds reported $319K of Medigus Ltd. Series C Warrant stock for Q4 2021, down 61% quarter-over-quarter.
- 1 fund opened new Medigus Ltd. Series C Warrant positions in Q4 2021 and 2 closed out, a net change of -1 holder.
- The largest Medigus Ltd. Series C Warrant seller in Q4 2021 was Warberg Asset Management, an estimated $9K sold.
Based on aggregated 13F filings for Q4 2021.